ATOSSA THERAPEUTICS, INC. Operating Expenses
ATOSSA THERAPEUTICS, INC. (ATOS) reported Operating Expenses of $8.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $8.69M, a 3.83% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $9.87M, a 33.13% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $11.44M, a 59.92% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $9.25M, a 44.89% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. operating expenses for fiscal 2025 was $37.14M, a 34.47% increase from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. operating expenses for fiscal 2024 was $27.62M, a 11.97% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. operating expenses for fiscal 2023 was $31.38M, a 13.31% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. operating expenses for fiscal 2022 was $27.69M, a 34.94% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 41 month | Operating Expenses 44 month | Operating Expenses 47 month | Operating Expenses 50 month | Operating Expenses 53 month | Operating Expenses 56 month | Operating Expenses 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.69M 10-Q · filed 2026-08-07 | $18.56M 10-Q · filed 2026-08-07 | $30.00M derived: sum of 3 quarters · filed 2026-08-07 | $39.25M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2026-03-31 | $9.87M 10-Q · filed 2026-05-08 | $21.31M derived: sum of 2 quarters · filed 2026-05-08 | $30.56M derived: sum of 3 quarters · filed 2026-05-08 | $39.60M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2025-12-31 | $11.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $20.69M derived: sum of 2 quarters · filed 2026-03-25 | $29.73M derived: sum of 3 quarters · filed 2026-08-07 | $37.14M 10-K · filed 2026-03-25 | |||||||||||
| 2025-09-30 | $9.25M 10-Q · filed 2025-11-12 | $18.29M derived: sum of 2 quarters · filed 2026-08-07 | $25.70M 10-Q · filed 2025-11-12 | $32.86M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2025-06-30 | $9.04M 10-Q · filed 2026-08-07 | $16.45M 10-Q · filed 2026-08-07 | $23.61M derived: sum of 3 quarters · filed 2026-08-07 | $29.99M derived: sum of 4 quarters · filed 2026-08-07 | |||||||||||
| 2025-03-31 | $7.41M 10-Q · filed 2026-05-08 | $14.56M derived: sum of 2 quarters · filed 2026-05-08 | $20.95M derived: sum of 3 quarters · filed 2026-05-08 | $28.05M derived: sum of 4 quarters · filed 2026-05-08 | |||||||||||
| 2024-12-31 | $7.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $13.54M derived: sum of 2 quarters · filed 2026-03-25 | $20.64M derived: sum of 3 quarters · filed 2026-03-25 | $27.62M 10-K · filed 2026-03-25 | |||||||||||
| 2024-09-30 | $6.38M 10-Q · filed 2025-11-12 | $13.49M derived: sum of 2 quarters · filed 2025-11-12 | $20.47M 10-Q · filed 2025-11-12 | $29.49M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||
| 2024-06-30 | $7.11M 10-Q · filed 2025-08-12 | $14.09M 10-Q · filed 2025-08-12 | $23.10M derived: sum of 3 quarters · filed 2025-08-12 | $30.57M derived: sum of 4 quarters · filed 2025-08-12 | |||||||||||
| 2024-03-31 | $6.98M 10-Q · filed 2025-05-13 | $16.00M derived: sum of 2 quarters · filed 2025-05-13 | $23.47M derived: sum of 3 quarters · filed 2025-05-13 | $31.26M derived: sum of 4 quarters · filed 2025-05-13 | |||||||||||
| 2023-12-31 | $9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $16.49M derived: sum of 2 quarters · filed 2025-03-25 | $24.28M derived: sum of 3 quarters · filed 2025-03-25 | $31.38M 10-K · filed 2025-03-25 | |||||||||||
| 2023-09-30 | $7.47M 10-Q · filed 2024-11-12 | $15.26M derived: sum of 2 quarters · filed 2024-11-12 | $22.36M 10-Q · filed 2024-11-12 | $30.50M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||
| 2023-06-30 | $7.79M 10-Q · filed 2024-08-12 | $14.89M 10-Q · filed 2024-08-12 | $23.03M derived: sum of 3 quarters · filed 2024-08-12 | $31.23M derived: sum of 4 quarters · filed 2024-08-12 | |||||||||||
| 2023-03-31 | $7.10M 10-Q · filed 2024-05-13 | $15.24M derived: sum of 2 quarters · filed 2024-05-13 | $23.44M derived: sum of 3 quarters · filed 2024-05-13 | $30.04M derived: sum of 4 quarters · filed 2024-05-13 | |||||||||||
| 2022-12-31 | $8.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $16.34M derived: sum of 2 quarters · filed 2024-04-01 | $22.94M derived: sum of 3 quarters · filed 2024-04-01 | $27.69M 10-K · filed 2024-04-01 | |||||||||||
| 2022-09-30 | $8.21M 10-Q · filed 2023-11-13 | $14.80M derived: sum of 2 quarters · filed 2023-11-13 | $19.55M 10-Q · filed 2023-11-13 | $24.38M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||
| 2022-06-30 | $6.59M 10-Q · filed 2023-08-14 | $11.35M 10-Q · filed 2023-08-14 | $16.17M derived: sum of 3 quarters · filed 2023-08-14 | $21.33M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||
| 2022-03-31 | $4.75M 10-Q · filed 2023-05-15 | $9.57M derived: sum of 2 quarters · filed 2023-05-15 | $14.73M derived: sum of 3 quarters · filed 2023-05-15 | $21.74M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||
| 2021-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $9.99M derived: sum of 2 quarters · filed 2023-03-22 | $16.99M derived: sum of 3 quarters · filed 2023-03-22 | $20.52M 10-K · filed 2023-03-22 | |||||||||||
| 2021-09-30 | $5.16M 10-Q · filed 2022-11-07 | $5.16M 10-Q · filed 2021-11-15 | $12.16M derived: sum of 2 quarters · filed 2022-11-07 | $15.69M 10-Q · filed 2022-11-07 | $15.69M 10-Q · filed 2021-11-15 | $19.92M derived: sum of 4 quarters · filed 2022-11-07 | |||||||||
| 2021-06-30 | $7.00M 10-Q · filed 2022-08-08 | $7.00M 10-Q · filed 2021-08-13 | $10.53M 10-Q · filed 2022-08-08 | $10.53M 10-Q · filed 2021-08-13 | $14.76M derived: sum of 3 quarters · filed 2022-08-08 | $18.27M derived: sum of 4 quarters · filed 2022-08-08 | |||||||||
| 2021-03-31 | $3.53M 10-Q · filed 2022-05-09 | $3.53M 10-Q · filed 2021-05-14 | $7.76M derived: sum of 2 quarters · filed 2022-05-09 | $11.27M derived: sum of 3 quarters · filed 2022-05-09 | $15.20M derived: sum of 4 quarters · filed 2022-05-09 | ||||||||||
| 2020-12-31 | $4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $7.73M derived: sum of 2 quarters · filed 2022-02-28 | $11.67M derived: sum of 3 quarters · filed 2022-02-28 | $14.61M 10-K · filed 2022-02-28 | $14.61M 10-K · filed 2021-03-31 | ||||||||||
| 2020-09-30 | $3.51M 10-Q · filed 2021-11-15 | $7.44M derived: sum of 2 quarters · filed 2021-11-15 | $10.38M 10-Q · filed 2021-11-15 | $13.00M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||
| 2020-06-30 | $3.94M 10-Q · filed 2021-08-13 | $6.87M 10-Q · filed 2021-08-13 | $9.49M derived: sum of 3 quarters · filed 2021-08-13 | $12.79M derived: sum of 4 quarters · filed 2021-08-13 | |||||||||||
| 2020-03-31 | $2.94M 10-Q · filed 2021-05-14 | $5.55M derived: sum of 2 quarters · filed 2021-05-14 | $8.85M derived: sum of 3 quarters · filed 2021-05-14 | $16.14M derived: sum of 4 quarters · filed 2021-05-14 | |||||||||||
| 2019-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $5.92M derived: sum of 2 quarters · filed 2021-03-31 | $13.20M derived: sum of 3 quarters · filed 2021-03-31 | $17.27M 10-K · filed 2021-03-31 | |||||||||||
| 2019-09-30 | $3.30M 10-Q · filed 2020-11-13 | $10.58M derived: sum of 2 quarters · filed 2020-11-13 | $14.65M 10-Q · filed 2020-11-13 | $16.76M derived: sum of 4 quarters · filed 2020-11-13 | |||||||||||
| 2019-06-30 | $7.29M 10-Q · filed 2020-08-13 | $11.35M 10-Q · filed 2020-08-13 | $13.46M derived: sum of 3 quarters · filed 2020-08-13 | $16.77M derived: sum of 4 quarters · filed 2020-08-13 | |||||||||||
| 2019-03-31 | $4.06M 10-Q · filed 2020-05-13 | $6.17M derived: sum of 2 quarters · filed 2020-05-13 | $9.48M derived: sum of 3 quarters · filed 2020-05-13 | $13.62M derived: sum of 4 quarters · filed 2020-05-13 | |||||||||||
| 2018-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $5.42M derived: sum of 2 quarters · filed 2020-03-26 | $9.56M derived: sum of 3 quarters · filed 2020-03-26 | $11.43M 10-K · filed 2020-03-26 | |||||||||||
| 2018-09-30 | $3.31M 10-Q · filed 2019-11-13 | $7.45M derived: sum of 2 quarters · filed 2019-11-13 | $9.33M 10-Q · filed 2019-11-13 | $11.32M derived: sum of 4 quarters · filed 2019-11-13 | |||||||||||
| 2018-06-30 | $4.14M 10-Q · filed 2019-08-13 | $6.02M 10-Q · filed 2019-08-13 | $8.01M derived: sum of 3 quarters · filed 2019-08-13 | $10.07M derived: sum of 4 quarters · filed 2019-08-13 | |||||||||||
| 2018-03-31 | $1.87M 10-Q · filed 2019-05-13 | $3.87M derived: sum of 2 quarters · filed 2019-05-13 | $5.92M derived: sum of 3 quarters · filed 2019-05-13 | $7.82M derived: sum of 4 quarters · filed 2019-05-13 | |||||||||||
| 2017-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $4.05M derived: sum of 2 quarters · filed 2019-03-28 | $5.95M derived: sum of 3 quarters · filed 2019-03-28 | $7.65M 10-K · filed 2019-03-28 | |||||||||||
| 2017-09-30 | $2.06M 10-Q · filed 2018-11-14 | $3.95M derived: sum of 2 quarters · filed 2018-11-14 | $5.66M 10-Q · filed 2018-11-14 | $5.64M 10-Q · filed 2017-11-13 | $8.18M derived: sum of 4 quarters · filed 2018-11-14 | ||||||||||
| 2017-06-30 | $1.90M 10-Q/A · filed 2018-11-13 | $3.60M 10-Q/A · filed 2018-11-13 | $3.58M 10-Q · filed 2017-08-14 | $6.12M derived: sum of 3 quarters · filed 2018-11-13 | $7.68M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||
| 2017-03-31 | $1.70M 10-Q · filed 2018-05-14 | $1.69M 10-Q · filed 2017-05-11 | $4.23M derived: sum of 2 quarters · filed 2018-05-14 | $5.79M derived: sum of 3 quarters · filed 2018-05-14 | $7.51M derived: sum of 4 quarters · filed 2018-05-14 | ||||||||||
| 2016-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $4.08M derived: sum of 2 quarters · filed 2018-03-08 | $5.80M derived: sum of 3 quarters · filed 2018-03-08 | $7.97M 10-K · filed 2018-03-08 | |||||||||||
| 2016-09-30 | $1.56M 10-Q · filed 2017-11-13 | $3.28M derived: sum of 2 quarters · filed 2017-11-13 | $5.44M 10-Q · filed 2017-11-13 | $7.95M derived: sum of 4 quarters · filed 2017-11-13 | |||||||||||
| 2016-06-30 | $1.72M 10-Q · filed 2017-08-14 | $4.05M 10-Q · filed 2017-08-14 | $6.39M derived: sum of 3 quarters · filed 2017-08-14 | $10.24M derived: sum of 4 quarters · filed 2017-08-14 | |||||||||||
| 2016-03-31 | $2.33M 10-Q · filed 2017-05-11 | $4.67M derived: sum of 2 quarters · filed 2017-05-11 | $8.51M derived: sum of 3 quarters · filed 2017-05-11 | $11.68M derived: sum of 4 quarters · filed 2017-05-11 | |||||||||||
| 2015-12-31 | $2.34M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $6.19M derived: sum of 2 quarters · filed 2017-03-21 | $9.36M derived: sum of 3 quarters · filed 2017-03-21 | $12.63M 10-K/A · filed 2017-03-21 | |||||||||||
| 2015-09-30 | $3.84M 10-Q/A · filed 2017-03-21 | $4.85M 10-Q · filed 2015-11-12 | $7.01M derived: sum of 2 quarters · filed 2017-03-21 | $10.28M 10-Q/A · filed 2017-03-21 | $12.83M 10-Q · filed 2015-11-12 | $13.62M derived: sum of 4 quarters · filed 2017-03-21 | |||||||||
| 2015-06-30 | $3.17M 10-Q/A · filed 2017-03-21 | $4.03M 10-Q · filed 2015-08-06 | $6.44M 10-Q/A · filed 2017-03-21 | $7.98M 10-Q · filed 2015-08-06 | $9.77M derived: sum of 3 quarters · filed 2017-03-21 | $13.02M derived: sum of 4 quarters · filed 2017-03-21 | |||||||||
| 2015-03-31 | $3.27M 10-Q/A · filed 2017-03-21 | $3.95M 10-Q · filed 2015-05-13 | $6.60M derived: sum of 2 quarters · filed 2017-03-21 | $9.85M derived: sum of 3 quarters · filed 2017-03-21 | $13.05M derived: sum of 4 quarters · filed 2017-03-21 | ||||||||||
| 2014-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $6.58M derived: sum of 2 quarters · filed 2016-03-30 | $9.78M derived: sum of 3 quarters · filed 2016-03-30 | $12.21M 10-K · filed 2016-03-30 | $14.83M 10-K · filed 2015-03-30 | ||||||||||
| 2014-09-30 | $3.25M 10-Q · filed 2015-11-12 | $6.45M derived: sum of 2 quarters · filed 2015-11-12 | $8.88M 10-Q · filed 2015-11-12 | $11.50M derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||
| 2014-06-30 | $3.20M 10-Q · filed 2015-08-06 | $5.63M 10-Q · filed 2015-08-06 | $8.26M derived: sum of 3 quarters · filed 2015-08-06 | $11.81M derived: sum of 4 quarters · filed 2015-08-06 | |||||||||||
| 2014-03-31 | $2.44M 10-Q · filed 2015-05-13 | $5.06M derived: sum of 2 quarters · filed 2015-05-13 | $8.61M derived: sum of 3 quarters · filed 2015-05-13 | $11.30M derived: sum of 4 quarters · filed 2015-05-13 | $23.38M 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $6.18M derived: sum of 2 quarters · filed 2015-03-30 | $8.86M derived: sum of 3 quarters · filed 2015-03-30 | $10.92M 10-K · filed 2015-03-30 | $20.94M 10-K · filed 2014-03-27 | ||||||||||
| 2013-09-30 | $3.55M 10-Q · filed 2014-11-12 | $6.24M derived: sum of 2 quarters · filed 2014-11-12 | $8.30M 10-Q · filed 2014-11-12 | $10.10M derived: sum of 4 quarters · filed 2014-11-12 | $18.32M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | $2.69M 10-Q · filed 2014-08-12 | $4.74M 10-Q · filed 2014-08-12 | $6.54M derived: sum of 3 quarters · filed 2014-08-12 | $7.77M derived: sum of 4 quarters · filed 2014-08-12 | $14.76M 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $2.06M 10-Q · filed 2014-05-14 | $3.86M derived: sum of 2 quarters · filed 2014-05-14 | $5.08M derived: sum of 3 quarters · filed 2014-05-14 | $6.45M derived: sum of 4 quarters · filed 2014-05-14 | $12.08M 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $3.02M derived: sum of 2 quarters · filed 2014-03-27 | $4.40M derived: sum of 3 quarters · filed 2014-03-27 | $5.49M 10-K · filed 2014-03-27 | $10.02M 10-K · filed 2013-03-28 | ||||||||||
| 2012-09-30 | $1.23M 10-Q · filed 2013-11-12 | -$1.23M 10-Q/A · filed 2013-01-22 | $2.60M derived: sum of 2 quarters · filed 2013-11-12 | $3.69M 10-Q · filed 2013-11-12 | -$3.69M 10-Q/A · filed 2013-01-22 | $9.25M derived: sum of 4 quarters · filed 2013-11-12 | -$8.22M 10-Q/A · filed 2013-01-22 | ||||||||
| 2012-06-30 | $1.37M 10-Q · filed 2013-08-14 | $2.46M 10-Q · filed 2013-08-14 | $8.03M derived: sum of 3 quarters · filed 2013-08-14 | $6.75M derived: sum of 4 quarters · filed 2013-08-14 | |||||||||||
| 2012-03-31 | $1.09M 10-Q · filed 2013-05-15 | $6.66M derived: sum of 2 quarters · filed 2013-05-15 | $5.38M derived: sum of 3 quarters · filed 2013-05-15 | ||||||||||||
| 2011-12-31 | $5.57M derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $4.29M derived: sum of 2 quarters · filed 2013-03-28 | $3.33M 10-K · filed 2013-03-28 | ||||||||||||
| 2011-09-30 | -$1.27M 10-Q/A · filed 2013-01-22 | -$2.23M 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |